Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin

BACKGROUND: Malignant mesotheliomas (MM) have a poor prognosis, largely because of their chemoresistance to anti-cancer drugs such as doxorubicin (Dox). Here we show using human MM lines that Dox activates extracellular signal-regulated kinases (ERK1 and 2), causally linked to increased expression o...

Descripción completa

Detalles Bibliográficos
Autores principales: Shukla, Arti, Hillegass, Jedd M, MacPherson, Maximilian B, Beuschel, Stacie L, Vacek, Pamela M, Pass, Harvey I, Carbone, Michele, Testa, Joseph R, Mossman, Brooke T
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016286/
https://www.ncbi.nlm.nih.gov/pubmed/21159167
http://dx.doi.org/10.1186/1476-4598-9-314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016286/
https://www.ncbi.nlm.nih.gov/pubmed/21159167
http://dx.doi.org/10.1186/1476-4598-9-314

Ejemplares similares